Supernus Pharmaceuticals, Inc.
2019 Q4 - 2026 Q1 (26 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2026 Q1 | 4/20/2026 | 1,313 | 0.0% | 25,400 | 3/31/2026 |
| 2025 Q4 | 1/16/2026 | 1,307 | 0.0% | 26,300 | 12/31/2025 |
| 2025 Q3 | 10/22/2025 | 1,233 | 0.0% | 25,800 | 9/30/2025 |
| 2025 Q2 | 7/23/2025 | 826 | 0.0% | 26,200 | 6/30/2025 |
| 2025 Q1 | 5/1/2025 | 852 | 0.0% | 26,000 | 3/31/2025 |
| 2024 Q4 | 1/29/2025 | 965 | 0.0% | 26,700 | 12/31/2024 |
| 2024 Q3 | 10/23/2024 | 829 | 0.0% | 26,600 | 9/30/2024 |
| 2024 Q2 | 7/24/2024 | 741 | 0.0% | 27,700 | 6/30/2024 |
| 2024 Q1 | 4/23/2024 | 924 | 0.0% | 27,100 | 3/31/2024 |
| 2023 Q4 | 1/29/2024 | 790 | 0.0% | 27,300 | 12/31/2023 |
| 2023 Q3 | 10/17/2023 | 766 | 0.0% | 27,800 | 9/30/2023 |
| 2023 Q2 | 7/18/2023 | 860 | 0.0% | 28,600 | 6/30/2023 |
| 2023 Q1 | 4/19/2023 | 913 | 0.0% | 25,200 | 3/31/2023 |
| 2022 Q4 | 1/24/2023 | 917 | 0.0% | 25,700 | 12/31/2022 |
| 2022 Q3 | 10/19/2022 | 867 | 0.0% | 25,600 | 9/30/2022 |
| 2022 Q2 | 7/20/2022 | 773 | 0.0% | 25,800 | 6/30/2022 |
| 2022 Q1 | 4/22/2022 | 768 | 0.0% | 25,900 | 3/31/2022 |
| 2021 Q4 | 1/14/2022 | 749 | 0.0% | 25,700 | 12/31/2021 |
| 2021 Q3 | 10/12/2021 | 683 | 0.0% | 25,600 | 9/30/2021 |
| 2021 Q2 | 7/16/2021 | 736 | 0.0% | 23,900 | 6/30/2021 |
| 2021 Q1 | 4/14/2021 | 628 | 0.0% | 24,000 | 3/31/2021 |
| 2020 Q4 | 1/11/2021 | 611 | 0.0% | 24,300 | 12/31/2020 |
| 2020 Q3 | 10/19/2020 | 508 | 0.0% | 24,400 | 9/30/2020 |
| 2020 Q2 | 7/13/2020 | 340 | 0.0% | 14,310 | 6/30/2020 |
| 2020 Q1 | 4/13/2020 | 261 | 0.0% | 14,510 | 3/31/2020 |
| 2019 Q4 | 1/17/2020 | 427 | 0.0% | 17,990 | 12/31/2019 |